�ٺ���Ƶ

News from �ٺ���Ƶ Health

My Kid Is Going Off To College – And I’m Going With Them. (New York Post)

The (3/4) Instead of a parent’s concerns, “The reasons for [a family] moving [when a child goes to college] should be to focused on meeting the needs of the young adult – eg, need more parent support, living at home instead of dorms, additional executive functioning support, etc.,” Yamalis Diaz, PhD, clinical associate professor, Department of Child and Adolescent Psychiatry, told The Post.

What Is Hand, Foot, And Mouth Disease? Understand This Viral Infection. (USA Today)

(3/6) “’The classic hand, foot, and mouth rash can also be experienced on the buttocks, legs around the mouth, and is sometimes more widespread on the body,’ says Vikash S. Oza, MD, associate professor, the Ronald O. Perelman Department of Dermatology, and associate professor, Department of Pediatrics.”

FDA Greenlights Amtagvi: New Hope For Treating Advanced Melanoma. (MDLinx)

(2/22) “This week, the United States Food and Drug Administration (FDA) approved Amtagvi (lifileucel), a first-of-its-kind cellular therapy used to treat solid tumors,” a type of therapy which may “may expand into other realms of cancer treatment,” with Janice Mehnert, MD, professor, Department of Medicine, Division of Hematology and Medical Oncology, Perlmutter Cancer Center, saying, “TIL approaches are being explored in other types of solid tumors, including lung, head and neck and cervical cancers.”

Is Spine Tech Advancing Too Fast? (Becker's Orthopedic & Spine Review)

(3/5) “‘Given the increasing rapidity of expanding technology and techniques, one major issue we need to address in spine surgery is the rapid adoption of novel techniques and technology just based on novelty, without adequate properly designed and honest research and training to support the optimal usage of these technologies,” said Peter G. Passias, MD, clinical associate professor, Department of Orthopedic Surgery.

THA For Acetabular Fracture May Have More Complications Vs. Femoral Neck Fracture. (Healio)

(3/5) “’The clear message was that geriatric acetabular fracture patients are a unique population that a certain set of orthopedic trauma and arthroplasty specialty centers should be treating, not necessarily in the community, if a total hip is considered,’ Vinay K. Aggarwal, MD, assistant professor, Department of Orthopedic Surgery, told Healio about results presented at the American Academy of Orthopaedic Surgeons Annual Meeting.”

How Are Endos Handling Weight-Loss Drug Shortages? (Medscape)

Paywall* (3/6)* Michael S. Phillips, MD, associate professor, Department of Medicine, Division of Infectious Diseases and Immunology, and chief epidemiologist, commented, ‘The risks of compounded GLP-1 RAs outweigh the possible benefits.”

Rybrevant (amivantamab-vmjw) In Combination With Chemotherapy Is The First FDA Approved Therapy For First-line Treatment Of Patients With Non-Small Cell Lung Cancer With EGFR Exon 20 Insertion Mutations. (Drug Information Online)

(3/1) Joshua K. Sabari, MD, assistant professor, Department of Medicine, Division of Hematology and Medical Oncology, Perlmutter Cancer Center, and study investigator, said, “The results observed in the PAPILLON study showed significant improvement in progression-free survival, supporting the use of this regimen as the potential standard-of-care in the first-line treatment of these patients.”

These Hair Loss Treatments Actually Work, According To Dermatologists. (SELF Magazine)

(3/5) “‘Low-dose oral minoxidil has also been gaining traction as an effective and generally well-tolerated treatment for women with androgenetic alopecia,’ Kristen Lo Sicco, MD, associate professor, the Ronald O. Perelman Department of Dermatology, chief of service and director, Skin and Cancer Unit, tells SELF.”

An Apple Vision Pro Rival Has Been In The VR Game Longer And Gone A Lot Further. (Quartz)

(3/5) reports, “Taiwanese consumer electronics company HTC has been making virtual reality headsets for years” where they are “in use by hospitals, militaries, and businesses all over the world,” including at “Boston Children’s Hospital, �ٺ���Ƶ Health, and USCF Benioff Children’s hospital.”

What Are The Diseases Aphasia And Frontotemporal Dementia? (Philadelphia Tribune)

The (3/5) “The most accurate term would be frontotemporal lobar degeneration, which is more specific to the process going on in the brain, said Joel Salinas, MD, MBA, clinical assistant professor, Department of Neurology, the Pearl I. Barlow Center for Memory Evaluation and Treatment, and chief medical officer of Isaac Health.”

Boyd Street Ventures Invests In HealthTech Innovator Watkins-Conti. (WIVB-TV Buffalo (NY))

Buffalo, NY (3/5) “Boyd Street Ventures announced that it has invested in Watkins-Conti Products, a HeathTech innovator,” whose flagship product, Yōni. Fit, “recently completed a clinical trial documenting the safety and effectiveness of the product” that was “led by urogynecologists at Stanford University, �ٺ���Ƶ Health, and Jefferson Health.”

Why Don’t Humans Have Tails. (Across America Patch)

(3/5) “A study published last week in the journal Nature sheds more light on how we became tailless,” was led by Bo Xia, formerly a graduate student at NYU Grossman School of Medicine, who was inspired after he “injured himself when he sat on a seat belt buckle as he shifted to make room for another passenger.” Itai Yanai, PhD, professor, Department of Biochemistry and Molecular Pharmacology, a co-author of the study, told The AP that losing our tails was clearly a major transition.”

Over-The-Counter Birth Control To Be Available In US In Weeks. (TODAY)

(3/5) “NBC medical contributor Natalie E. Azar, MD, clinical associate professor, Department of Medicine, Division of Rheumatology, joins TODAY to discuss that in “a few weeks, Americans will be able to buy the over-the-counter birth control medication called Opill for the first time.”